Skip to main content
GH
NASDAQ Life Sciences

$500M Convertible Notes Offering Announced, With 2027 Note Repurchase

Tom Rudovsky · Reported by BusinessWire
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$154.78
Mkt Cap
$20.94B
52W Low
$74.55
52W High
$191.05
52W Position info
108% above low
Off High info
19% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

GH has more than doubled off its 52-week low of $74.55.

Summary

Guardant is selling $500.0 million of convertible senior notes due 2032 in a Rule 144A private placement, with an option for up to $50.0 million more. Terms — coupon, conversion rate — aren't set yet; they price at market. Part of the proceeds goes to repurchase a slice of its 0% convertible notes due 2027, and part funds capped call transactions meant to blunt dilution from conversion. The rest is for general corporate purposes, including possible acquisitions, though the company says it has no agreements in place. Convertible issuance typically pressures the stock on announcement given dilution and hedge-related selling, and this comes right after Q3 revenue of $361.0 million, up 36%, with the net loss widening to $124.4 million. Pricing terms will determine how much real dilution lands.

At the time of this announcement, GH was trading at $154.78 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $20.9B. The 52-week trading range was $74.55 to $191.05. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

GH - Latest Insights

GH
Nov 05, 2026, 5:13 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $130.02
Real-time Price: $149.98 info
Change: +$19.96 (+15%) info
Market Cap: $20.94B info
GH
Nov 05, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $159.34
Real-time Price: $149.98 info
Change: -$9.36 (-6%) info
Market Cap: $20.94B info
GH
Oct 08, 2026, 4:12 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $165.56
Real-time Price: $149.98 info
Change: -$15.58 (-9%) info
Market Cap: $20.94B info
GH
Sep 04, 2026, 3:44 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $156.46
Real-time Price: $149.98 info
Change: -$6.48 (-4%) info
Market Cap: $20.94B info
GH
Aug 24, 2026, 7:20 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $170.05
Real-time Price: $149.98 info
Change: -$20.07 (-12%) info
Market Cap: $20.94B info